Adirondack Trust Company’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $545K | Sell |
5,269
-40
| -0.8% | -$3.57K | 0.16% | 96 |
|
|
2026
Q1 | $381K | Sell |
5,309
-287
| -5% | -$22.1K | 0.13% | 106 |
|
|
2025
Q4 | $444K | Sell |
5,596
-109
| -2% | -$8.59K | 0.15% | 100 |
|
|
2025
Q3 | $430K | Sell |
5,705
-3,017
| -35% | -$207K | 0.14% | 101 |
|
|
2025
Q2 | $602K | Sell |
8,722
-319
| -4% | -$20.9K | 0.22% | 90 |
|
|
2025
Q1 | $613K | Sell |
9,041
-737
| -8% | -$44.1K | 0.24% | 86 |
|
|
2024
Q4 | $439K | Sell |
9,778
-1,494
| -13% | -$83.8K | 0.17% | 99 |
|
|
2024
Q3 | $709K | Sell |
11,272
-802
| -7% | -$46.8K | 0.27% | 75 |
|
|
2024
Q2 | $713K | Buy |
12,074
+98
| +0.8% | +$6.13K | 0.29% | 70 |
|
|
2024
Q1 | $955K | Sell |
11,976
-52
| -0.4% | -$3.97K | 0.4% | 62 |
|
|
2023
Q4 | $894K | Sell |
12,028
-141
| -1% | -$10K | 0.39% | 63 |
|
|
2023
Q3 | $849K | Buy |
12,169
+239
| +2% | +$16.9K | 0.42% | 61 |
|
|
2023
Q2 | $891K | Buy |
11,930
+1,111
| +10% | +$79.1K | 0.42% | 61 |
|
|
2023
Q1 | $804K | Sell |
10,819
-13
| -0.1% | -$1.09K | 0.41% | 63 |
|
|
2022
Q4 | $1.01M | Sell |
10,832
-1
| -0% | -$96 | 0.52% | 49 |
|
|
2022
Q3 | $1.03M | Buy |
10,833
+185
| +2% | +$18.3K | 0.58% | 41 |
|
|
2022
Q2 | $987K | Buy |
10,648
+37
| +0.3% | +$3.61K | 0.53% | 46 |
|
|
2022
Q1 | $1.07M | Buy |
10,611
+497
| +5% | +$52.2K | 0.51% | 47 |
|
|
2021
Q4 | $1.04M | Sell |
10,114
-540
| -5% | -$49.9K | 0.5% | 50 |
|
|
2021
Q3 | $951K | Sell |
10,654
-246
| -2% | -$20.6K | 0.45% | 56 |
|
|
2021
Q2 | $909K | Sell |
10,900
-25
| -0.2% | -$2.05K | 0.46% | 56 |
|
|
2021
Q1 | $822K | Buy |
10,925
+1,175
| +12% | +$85.6K | 0.44% | 56 |
|
|
2020
Q4 | $699K | Buy |
9,750
+5
| +0.1% | +$325 | 0.42% | 58 |
|
|
2020
Q3 | $569K | Sell |
9,745
-115
| -1% | -$7.16K | 0.37% | 62 |
|
|
2020
Q2 | $620K | Sell |
9,860
-240
| -2% | -$15.1K | 0.41% | 58 |
|
|
2020
Q1 | $599K | Buy |
10,100
+1,285
| +15% | +$85.8K | 0.49% | 49 |
|
|
2019
Q4 | $598K | Sell |
8,815
-276
| -3% | -$19.4K | 0.39% | 59 |
|
|
2019
Q3 | $573K | Sell |
9,091
-1,635
| -15% | -$96.9K | 0.4% | 54 |
|
|
2019
Q2 | $584K | Hold |
10,726
| – | – | 0.41% | 54 |
|
|
2019
Q1 | $583K | Buy |
10,726
+163
| +2% | +$10.1K | 0.4% | 55 |
|
|
2018
Q4 | $692K | Buy |
10,563
+1,675
| +19% | +$125K | 0.54% | 46 |
|
|
2018
Q3 | $700K | Sell |
8,888
-1,020
| -10% | -$72.9K | 0.47% | 48 |
|
|
2018
Q2 | $638K | Sell |
9,908
-160
| -2% | -$10.5K | 0.45% | 49 |
|
|
2018
Q1 | $703K | Buy |
10,068
+530
| +6% | +$38K | 0.5% | 48 |
|
|
2017
Q4 | $692K | Sell |
9,538
-1,660
| -15% | -$121K | 0.5% | 48 |
|
|
2017
Q3 | $911K | Sell |
11,198
-150
| -1% | -$11.9K | 0.72% | 40 |
|
|
2017
Q2 | $913K | Sell |
11,348
-3,390
| -23% | -$268K | 0.74% | 37 |
|
|
2017
Q1 | $1.16M | Sell |
14,738
-1,215
| -8% | -$97K | 0.81% | 32 |
|
|
2016
Q4 | $1.26M | Buy |
15,953
+2,021
| +15% | +$164K | 0.88% | 29 |
|
|
2016
Q3 | $1.24M | Buy |
13,932
+145
| +1% | +$13.7K | 0.89% | 27 |
|
|
2016
Q2 | $1.32M | Buy |
13,787
+50
| +0.4% | +$4.98K | 0.94% | 26 |
|
|
2016
Q1 | $1.42M | Buy |
13,737
+110
| +0.8% | +$10.7K | 1.06% | 23 |
|
|
2015
Q4 | $1.32M | Sell |
13,627
-325
| -2% | -$31.8K | 1.04% | 26 |
|
|
2015
Q3 | $1.35M | Buy |
13,952
+769
| +6% | +$80.8K | 1.08% | 21 |
|
|
2015
Q2 | $1.38M | Buy |
13,183
+230
| +2% | +$23.5K | 1.03% | 26 |
|
|
2015
Q1 | $1.34M | Buy |
12,953
+295
| +2% | +$29.8K | 1% | 26 |
|
|
2014
Q4 | $1.22M | Sell |
12,658
-280
| -2% | -$24.7K | 0.91% | 30 |
|
|
2014
Q3 | $1.03M | Sell |
12,938
-200
| -2% | -$15.8K | 0.78% | 36 |
|
|
2014
Q2 | $990K | Sell |
13,138
-285
| -2% | -$21.5K | 0.76% | 35 |
|
|
2014
Q1 | $1M | Sell |
13,423
-655
| -5% | -$46.3K | 0.8% | 34 |
|
|
2013
Q4 | $1.01M | Buy |
14,078
+300
| +2% | +$19.3K | 0.82% | 34 |
|
|
2013
Q3 | $782K | Buy |
13,778
+800
| +6% | +$47.7K | 0.69% | 38 |
|
|
2013
Q2 | $742K | Buy |
+12,978
| New | +$752K | 0.67% | 39 |
|
Other funds holding CVS
Adirondack Trust Company's CVS Position: Q2 2026 in Review
Adirondack Trust Company reduced its CVS Health (CVS) stake by 0.75% in Q2 2026, selling an estimated $3.57K and leaving 5,269 shares worth $545K. The position accounts for 0.16% of the portfolio, ranked #96.
Adirondack Trust Company first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.42M in Q1 2016. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Adirondack Trust Company held 5,269 shares of CVS Health worth $545K as of Q2 2026.
- Adirondack Trust Company sold 40 CVS Health shares in Q2 2026, an estimated $3.57K.
- CVS Health made up 0.16% of Adirondack Trust Company's portfolio in Q2 2026, its #96 holding.
- Adirondack Trust Company first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Adirondack Trust Company's CVS Health position peaked at $1.42M in Q1 2016.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.